GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Consumer inclination to balance convenience with sustainability fuels packaging innovations in Vietnam, says GlobalData

The return to normalcy after the COVID-19 pandemic also brings back long commutes and hectic workdays for consumers, who increasingly seek food & drinks in convenient and easy to use formats. Furthermore, growing eco-conscious consumerism is spurring opportunities for brands to use innovative packaging, says GlobalData, a leading data and analytics company. Meenakshi Haran, Lead […]
Read more

Chips industry may not be fit for purpose by 2030, says GlobalData

Next-generation chips represent the next frontier of semiconductor technology, incorporating advancements in design, materials, manufacturing process, performance, and packaging. As computing tasks become more demanding and data-intensive, next-generation chips promise faster speeds and better energy efficiency. However, the chips industry faces significant technological, supply chain, and geopolitical challenges, which will only intensify over the next […]
Read more

Crypto hiring thrives in Q1 2024, but April slump highlights volatility and regulatory concerns, says GlobalData

Cryptocurrency-related hiring activity remained strong in the first quarter (Q1) of 2024 and registered quarter-on-quarter (QoQ) growth as companies such as Coinbase Global and Binance Holdings posted significant number of jobs. Yet, April saw a slowdown, indicating challenges amid market volatility and regulatory uncertainties, reveals the Job Analytics Database of GlobalData, a leading data and […]
Read more

Roche challenges Regeneron and Bayer’s position as industry leaders within wAMD, DME and DR spaces, says GlobalData

Roche’s Vabysmo (faricimab) is in the spotlight following its promising Q1 2024 sales figures. Vabysmo, a vascular endothelial growth factor (VEGF) inibitior and angiopoietin-2 (Ang-2) inhibitor therapy, is indicated for wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and macular edema following retinal vein occlusion (RVO). This presents a looming challenge to Regeneron and […]
Read more

Payment cards continue to lead e-commerce payments in South Korea with 54% share, reveals GlobalData

Payment cards remain the most preferred payment tool for e-commerce purchases in South Korea, collectively accounting for over half (54%) of the total e-commerce payments in 2023, signifying a strong preference for secure and convenient transactions among the online shoppers, finds GlobalData, a leading data and analytics company. GlobalData’s E-Commerce Analytics reveals that the e-commerce […]
Read more

Coinbase dominates Reddit discussions amongst top crypto trading platforms during Q1 2024, reveals GlobalData

As the cryptocurrency market once again experiences volatility post a strong Q1 2024 surge, investors face fresh uncertainty. The recent price dip raises doubts about the sustainability of the rebound, emphasizing the persistent volatility of digital assets. Consequently, market participants navigate uncertain terrain, recognizing the inherent risks at play. Against this backdrop, Coinbase Global Inc […]
Read more

Anticipation builds as Insmed bronchiectasis therapy brensocatib nears Phase III completion, observes GlobalData

Insmed is in the spotlight over the past few years for its pipeline agent, brensocatib, which has previously shown promising Phase II results, generating anticipation within the medical community ahead of their Phase III results for the treatment of bronchiectasis. The positive outcomes could pave the way for regulatory approval, potentially transforming the therapeutic landscape […]
Read more

Three BiTEs set to disrupt relapsed/recurrent multiple myeloma space with $9 billion sales by 2030, says GlobalData

Recent developments in the field of bispecific T-cell engagers (BiTEs) have led to the approval of three therapies for relapsed/recurrent multiple myeloma (RRMM): Elrexfio (elranatamab) developed by Pfizer, Tecvayli (teclistamab) and Talvey (talquetamab) developed by Johnson & Johnson. Clinical data of the three have been surprising, surpassing previously anticipated response rates. With an ever-growing number […]
Read more

Network APIs gain traction but telcos risk being left behind with regulation and standardization challenges, says GlobalData

2024 has finally seen Network Application Programming Interfaces (APIs) gain commercial traction for both mobile and fixed networks in multiple markets across the globe. Mobile network operators across Europe, Asia, and the Americas have latched on to the GSMA Open Gateway’s antifraud APIs, with strong interest from businesses already being reported. However, these are early […]
Read more

APAC automotive active and passive safety systems market to expand at 2.6% CAGR over 2023-28, forecasts GlobalData

The increased prevalence of automotive active and passive safety systems can be attributed to an array of factors, including a heightened awareness of safety concerns among consumers and government regulations aimed at improving safety standards. Against this backdrop, the active and passive safety systems market is forecast to post a compound annual growth rate (CAGR) […]
Read more

Cell and gene manufacturers benefit from surge in FDA drug approvals, says GlobalData

2023 marked a significant upsurge in FDA approvals, particularly for groundbreaking treatments such as cell and gene therapies. This surge highlights not just advancements in medical technology but also provides substantial opportunities for manufacturers specializing in these cutting-edge therapies. Looking ahead to 2024-25, the pharmaceutical industry braces for challenges marked by increasing drug approvals, innovative […]
Read more

Digital twins gaining rapid acceptance in oil and gas operations, says GlobalData

Digital twins are digital representations of physical assets, systems, people, or processes. They help detect, prevent, predict, and optimize the physical environment using artificial intelligence (AI), real-time analytics, visualization, and simulation tools. In case of oil and gas, digital twins can support the entire project lifecycle from the project design to commissioning. It can also […]
Read more

ESCMID Global 2024 echoes multidisciplinary calls to action, finds GlobalData

Working towards a multidisciplinary approach to navigate the future of infectious diseases has been a key theme at the 34th European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global* 2024 congress. Key concerns such as climate change and antimicrobial resistance (AMR) were underscored, emphasizing the need for collaborative efforts beyond traditional medical realms. Initiatives […]
Read more
1 139 140 141 142 143 776